Refresh
Company Presentation • 02 May 2024 20:00
Company Presentation • 27 Mar 2024 21:00
Company Presentation • 22 Feb 2024 21:00
Company Presentation • 07 Dec 2023 21:00
Company Presentation • 08 Nov 2023 21:00
ENTITY
Moderna (MRNA US)
Moderna (MRNA US)
65
Analysis
Health Care • United States
Moderna, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
more
x